NCT02184858View on ClinicalTrials.gov

Dose Titration of Lisinopril in Children Aged 1 to 18 Years With Primary or Secondary Hypertension

PHASE4CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

June 25, 2014

Primary Completion Date

May 8, 2017

Study Completion Date

September 17, 2018

Conditions
Primary HypertensionSecondary Hypertension
Interventions
DRUG

lisinopril, ACE-inhibitor

Lisinopril 0.1mg/kg/d, titration with + 0.1mg/kg/d. Max; daily dose: 0.4mg/kg. CAVE: dose reduction in case of renal impairment

Trial Locations (1)

9000

Department of Pediatrics and Medical Genetics, Ghent

All Listed Sponsors
lead

University Ghent

OTHER

NCT02184858 - Dose Titration of Lisinopril in Children Aged 1 to 18 Years With Primary or Secondary Hypertension | Biotech Hunter | Biotech Hunter